Abstract
Sexual dysfunction is a major public health problem that negatively affects the lives of hundreds of millions of individuals worldwide. There is strong evidence suggesting that tobacco use and sexual dysfunction are linked. In fact, cigarette smoking is independently associated with an increased risk of erectile dysfunction (ED). This relationship has been observed among both current and former smokers and among both passive and active smokers, and many studies suggest a dose-response relationship. Further, prospective studies indicate that cigarette use increases the risk of incident ED, whereas smoking cessation appears to improve erectile function. The link between tobacco use (and disuse) and sexual function in women is relatively understudied, and results remain inconclusive. Future research would benefit from utilizing more prospective designs and assessing the effects of smoking (and particularly passive smoking) on a wider range of sexual function outcomes (physiological, sexual dysfunctions other than male and female arousal disorders), especially among women.
Similar content being viewed by others
References
Paper of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Centers for Disease Control and Prevention. Cigarette smoking among adults and trends in smoking cessation—United States, 2008. Morb Mortal Wkly Rep. 2008;58(44):1227–32.
Centers for Disease Control and Prevention. Smoking-attributable mortality, years of potential life lost, and productivity losses—United States, 2000--2004. Morb Mortal Wkly Rep. 2008;57(45):1226–8.
US Department of Health and Human Services. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the surgeon general. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2010.
Ohira T, Shahar E, Chambless LE, Rosamond WD, Mosley Jr TH, Folsom AR. Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities study. Stroke. 2006;37(10):2493–8.
U.S. Department of Health and Human Services. The health consequences of smoking: a report of the surgeon general. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health 2004.
Tengs TO, Osgood ND. The link between smoking and impotence: two decades of evidence. Prev Med. 2001;32(6):447–52.
McVary KT, Carrier S, Wessells H. Subcommittee on Smoking and Erectile Dysfunction Socioeconomic Committee Sexual Medicine Society of North America. Smoking and erectile dysfunction: evidence based analysis. J Urol. 2001;166(5):1624–32.
Millett C, Wen L, Rissel C, Smith A, Richters J, Grulich A, et al. Smoking and erectile dysfunction: findings from a representative sample of Australian men. Tob Control. 2006;15(2):136–9.
Lau JT, Wang Q, Cheng Y, Yang X. Prevalence and risk factors of sexual dysfunction among younger married men in a rural area in China. Urology. 2005;66(3):616–22.
Kupelian V, Link CL, McKinlay JB. Association between smoking, passive smoking, and erectile dysfunction: results from the Boston Area Community Health (BACH) Survey. Eur Urol. 2007;52(2):416–22.
Green J, Holden S, Ingram P, Bose P, St George D, Bowsher W. An investigation of erectile dysfunction in Gwent, Wales. BJU Int. 2001;88(6):551–3.
Bortolotti A, Fedele D, Chatenoud L, Colli E, Coscelli C, Landoni M, et al. Cigarette smoking: a risk factor for erectile dysfunction in diabetics. Eur Urol. 2001;40(4):392–7.
Austoni E, Mirone V, Parazzini F, Fasolo CB, Turchi P, Pescatori ES, et al. Smoking as a risk factor for erectile dysfunction: data from the Andrology Prevention Weeks 2001-2002: a study of the Italian Society of Andrology (SIA). Eur Urol. 2005;48(5):810–8.
Blanker MH, Bohnen AM, Groeneveld FP, Bernsen R, Prins A, Thomas S, et al. Correlates for erectile and ejaculatory dysfunction in older Dutch men: a community-based study. J Am Geriatr Soc. 2001;49(4):436–42.
Gades NM, Nehra A, Jacobson DJ, McGree ME, Girman CJ, Rhodes T, et al. Association between smoking and erectile dysfunction: a population-based study. Am J Epidemiol. 2005;161(4):346–51.
He J, Reynolds K, Chen J, Chen CS, Wu X, Duan X, et al. Cigarette smoking and erectile dysfunction among Chinese men without clinical vascular disease. Am J Epidemiol. 2007;166(7):803–9.
Lam TH, Abdullah AS, Ho LM, Yip AW, Fan S. Smoking and sexual dysfunction in Chinese males: findings from men’s health survey. Int J Impot Res. 2006;18(4):364–9.
Mannino DM, Klevens RM, Flanders WD. Cigarette smoking: an independent risk factor for impotence? Am J Epidemiol. 1994;140(11):1003–8.
Martin-Morales A, Sanchez-Cruz JJ, Saenz de Tejada I, Rodriguez-Vela L, Jimenez-Cruz JF, Burgos-Rodriguez R. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study. J Urol. 2001;166(2):569–74.
Mirone V, Imbimbo C, Bortolotti A, Di Cintio E, Colli E, Landoni M, et al. Cigarette smoking as risk factor for erectile dysfunction: results from an Italian epidemiological study. Eur Urol. 2002;41(3):294–7.
Moreira Jr ED, Bestane WJ, Bartolo EB, Fittipaldi JAS. Prevalence and determinants of erectile dysfunction in Santos, southeastern Brazil. Sao Paulo Med J. 2002;120(2):49–54.
Nicolosi A, Glasser DB, Moreira Jr ED, Villa M. Prevalence of erectile dysfunction and associated factors among men without concomitant diseases: a population study. Int J Impot Res. 2003;15(4):253–7.
Nicolosi A, Moreira Jr ED, Shirai M, Bin Mohd Tambi MI, Glasser DB. Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction. Urology. 2003;61(1):201–6.
Parazzini F, Fabris M, Bortolotti A, Calabro A, Chatenoud L, Colli E, et al. Frequency and determinants of erectile dysfunction in Italy. Eur Urol. 2000;37(1):43–9.
Safarinejad MR. Prevalence and risk factors for erectile dysfunction in a population-based study in Iran. Int J Impot Res. 2003;15(4):246–52.
Saigal CS, Wessells H, Pace J, Schonlau M, Wilt TJ. Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med. 2006;166(2):207–12.
Shiri R, Koskimaki J, Hakkinen J, Tammela TLJ, Huhtala H, Hakama M, et al. Effects of age, comorbidity and lifestyle factors on erectile function: Tampere Ageing Male Urological Study (TAMUS). Eur Urol. 2004;45(5):628–33.
Zedan H, Hareadei AA, Abd-Elsayed AA, Abdel-Maguid EM. Cigarette smoking, hypertension and diabetes mellitus as risk factors for erectile dysfunction in upper Egypt. East Mediterr Health J. 2010;16(3):281–5.
Dorey G. Is smoking a cause of erectile dysfunction? A literature review. Br J Nurs. 2001;10(7):455–65.
Akpinar E, Uysal Y, Bozdemir N, Saatci E, Bashan I. Prevalence of erectile dysfunction among Turkish heterosexual men. Sci J Med Sci. 2013;2(11):225–31.
Christensen B, Gronbaek M, Pedersen B, Graugaard C, Frisch M. Associations of unhealthy lifestyle factors with sexual inactivity and sexual dysfunctions in Denmark. J Sex Med. 2011;8(7):1903–16. A population-based sample of 2,120 Danish men showing that current smoking was a risk factor for ED, and former smoking was a risk factor for both ED and premature ejaculation.
Zambon JP, Mendonca RR, Wroclawski ML, Karam Junior A, Santos RD, Carvalho JA, et al. Cardiovascular and metabolic syndrome risk among men with and without erectile dysfunction: case-control study. Sao Paulo Med J. 2010;128(3):137–40.
Ghalayini IF, Al-Ghazo MA, Al-Azab R, Bani-Hani I, Matani YS, Barham AE, et al. Erectile dysfunction in a Mediterranean country: results of an epidemiological survey of a representative sample of men. Int J Impot Res. 2010;22(3):196–203. An epidemiological study of 905 Jordanian men showing that both current and former smoking are independent risk factors for ED.
Chew K-K, Bremner A, Stuckey B, Earle C, Jamrozik K. Is the relationship between cigarette smoking and male erectile dysfunction independent of cardiovascular disease? Findings from a population-based cross-sectional study. J Sex Med. 2009;6(1):222–31. A population-based cross-sectional study of 1,580 Australian men showing that current and former smoking was associated with an increased risk of ED even after controlling for cardiovascular disease.
Wu C, Zhang H, Gao Y, Tan A, Yang X, Lu Z, et al. The association of smoking and erectile dysfunction: results from the Fangchenggang Area Male Health and Examination Survey (FAMHES). J Androl. 2012;33(1):59–65. A population-based study of 4,303 Chinese men indicating that current smoking increased the risk of ED in a dose-dependent fashion.
Weber MF, Smith DP, O’Connell DL, Patel MI, de Souza PL, Sitas F, et al. Risk factors for erectile dysfunction in a cohort of 108 477 Australian men. Med J Aust. 2013;199(2):107–11. A population-based cross-sectional study of 8,477 men showing that both current and former smoking increased risk of ED.
Cao S, Yin X, Wang Y, Zhou H, Song F, Lu Z. Smoking and risk of erectile dysfunction: systematic review of observational studies with meta-analysis. PLoS One. 2013;8(4):e60443. A meta-analysis of 28,586 participants indicating the increased risk of ED among both current and former smokers.
Oksuz E, Malhan S. Prevalence and risk factors for female sexual dysfunction in Turkish women. J Urol. 2006;175:654–8.
West SL, D’Aloisio AA, Agans RP, Kalsbeek WD, Borisov NN, Thorp JM. Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women. Arch Intern Med. 2008;168(13):1441–9.
Rosen RC, Connor MK, Miyasato G, Link C, Shifren JL, Fisher WA, et al. Sexual desire problems in women seeking healthcare: a novel study design for ascertaining prevalence of hypoactive sexual desire disorder in clinic-based samples of U.S. women. J Womens Health. 2012;21(5):505–15. A national, clinic-based study of 701 women showing that current smoking was associated with increased risk of hypoactive sexual desire disorder.
Diehl A, Silva RL, Laranjeira R. Female sexual dysfunction in patients with substance-related disorders. Clinics (Sao Paulo). 2013;68(2):205–12.
Song SH, Jeon H, Kim SW, Paick JÄ, Son H. The prevalence and risk factors of female sexual dysfunction in young Korean women: an internet-based survey. J Sex Med. 2008;5(7):1694–701.
Hayes RD, Dennerstein L, Bennett CM, Sidat M, Gurrin LC, Fairley CK. Risk factors for female sexual dysfunction in the general population: exploring factors associated with low sexual function and sexual distress. J Sex Med. 2008;5(7):1681–93.
Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. J Am Med Assoc. 1999;281(6):537–44.
Elsamra S, Nazmy M, Shin D, Fisch H, Sawczuk I, Fromer D. Female sexual dysfunction in urological patients: findings from a major metropolitan area in the USA. BJU Int. 2010;106(4):524–6.
Safarinejad MR. Female sexual dysfunction in a population-based study in Iran: prevalence and associated risk factors. Int J Impot Res. 2006;18:382–95.
Wallner LP, Sarma AV, Kim C. Sexual functioning among women with and without diabetes in the Boston Area Community Health Study. J Sex Med. 2009;7:881–7.
Lianjun P, Aixia Z, Zhong W, Feng P, Li B, Xiaona Y. Risk factors for low sexual function among urban Chinese women: a hospital-based investigation. J Sex Med. 2011;8(8):2299–304.
Laumann EO, Glasser DB, Neves RCS, Moreira ED. A population-based survey of sexual activity, sexual problems and associated help-seeking behavior patterns in mature adults in the United States of America. Int J Impot Res. 2009;21(3):171–8.
Ponholzer A, Roehlich M, Racz U, Temml C, Madersbacher S. Female sexual dysfunction in a healthy Austrian cohort: prevalence and risk factors. Eur Urol. 2005;47(3):366–75.
Cabral PUL, Canario ACG, Spyrides MHC, Uchoa SAC, Eleuterio Jr J, Goncalves AK. Determinants of sexual dysfunction among middle-aged women. Int J Gynecol Obstet. 2013;120:271–4.
Cayan S, Akbay E, Bozlu M, Canpolat B, Acar D, Ulusoy E. The prevalence of female sexual dysfunction and potential risk factors that may impair sexual function in Turkish women. Urol Int. 2004;72:52–7.
Aslan E, Beji NK, Gungor I, Kadioglu A, Dikencik BK. Prevalence and risk factors for low sexual function in women: a study of 1,009 women in an outpatient clinic of a university hospital in Istanbul. J Sex Med. 2008;5(9):2044–52.
Esposito K, Maiorino M, Bellastella G, Giugliano F, Romano M, Giugliano D. Determinants of female sexual dysfunction in type 2 diabetes. Int J Impot Res. 2010;22(3):179–84.
Burri A, Spector T. Recent and lifelong sexual dysfunction in a female UK population sample: prevalence and risk factors. J Sex Med. 2011;8(9):2420–30.
Tostes RC, Carneiro FS, Lee AJ, Giachini FRC, Leite R, Osawa Y, et al. Cigarette smoking and erectile dysfunction: focus on NO bioavailability and ROS generation. J Sex Med. 2008;5(6):1284–95.
Feldman HA, Johannes CB, Derby CA, Kleinman KP, Mohr BA, Araujo AB, et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts Male Aging Study. Prev Med. 2000;30(4):328–38.
Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke nearly as large as smoking. Circulation. 2005;111(20):2684–98.
Polsky JY, Aronson KJ, Heaton JP, Adams MA. Smoking and other lifestyle factors in relation to erectile dysfunction. BJU Int. 2005;96(9):1355–9.
Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB. A prospective study of risk factors for erectile dysfunction. J Urol. 2006;176(1):217–21.
Shiri R, Koskimaki J, Hakama M, Hakkinen J, Huhtala H, Tammela TLJ, et al. Effect of life-style factors on incidence of erectile dysfunction. Int J Impot Res. 2004;16(5):389–94.
Shiri R, Hakkinen J, Koskimaki J, Tammela TLJ, Auvinen A, Hakama M. Smoking causes erectile dysfunction through vascular disease. Urology. 2006;68(6):1318–22.
Natali A, Mondaini N, Lombardi G, Del Popolo G, Rizzo M. Heavy smoking is an important risk factor for erectile dysfunction in young men. Int J Impot Res. 2005;17(3):227–30.
Bai Q, Xu QQ, Jiang H, Zhang W-L, Wang X-H, Zhu J-C. Prevalence and risk factors of erectile dysfunction in three cities of China: a community-based study. Asian J Androl. 2004;6(4):343–8.
Pourmand G, Alidaee MR, Rasuli S, Maleki A, Mehrsai A. Do cigarette smokers with erectile dysfunction benefit from stopping?: a prospective study. BJU Int. 2004;94(9):1310–3.
Derby CA, Mohr BA, Goldstein I, Feldman HA, Johannes CB, McKinlay JB. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology. 2000;56(2):302–6.
Moreira Jr ED, Lbo CFL, Diament A, Nicolosi A, Glasser DB. Incidence of erectile dysfunction in men 40 to 69 years old: results from a population-based cohort study in Brazil. Urology. 2003;61(2):431–6.
Smith AM, Lyons A, Ferris JA, Richters J, Pitts MK, Shelley JM, et al. Incidence and persistence/recurrence of women’s sexual difficulties: findings from the Australian Longitudinal Study of Health and Relationships. J Sex Mar Ther. 2012;38(4):378–93. A longitudinal cohort study of 2,252 Australian women assessing the incidence and persistence/recurrence of eight sexual difficulties. Smoking predicted the incidence but not the recurrence of low sexual desire.
McMahon CG, Touma K. Predictive value of patient history and correlation of nocturnal penile tumescence, colour duplex Doppler ultrasonography and dynamic cavernosometry and cavernosography in the evaluation of erectile dysfunction. Int J Impot Res. 1999;11(1):47–51.
Levine LA, Gerber GS. Acute vasospasm of penile arteries in response to cigarette smoking. Urology. 1990;36(1):99–100.
Elhanbly S, Abdel-Gaber S, Fathy H, El-Bayoumi Y, Wald M, Niederberger CS. Erectile dysfunction in smokers: a penile dynamic and vascular study. J Androl. 2004;25(6):991–5.
Vidal Moreno JF, Moreno Pardo B, Jimenez Cruz JF. Assessment of tobacco impact on penile vascularization with echo-Doppler and intracavernous injection. Actas Urol Esp. 1996;20(4):365–71.
Chung WS, Shim BS, Park YY. Hemodynamic insult by vascular risk factors and pharmacologic erection in men with erectile dysfunction: Doppler sonography study. World J Urol. 2000;18(6):427–30.
Hirshkowitz M, Arcasoy MO, Karacan I, Williams RL, Howell JW. Nocturnal penile tumescence in cigarette smokers with erectile dysfunction. Urology. 1992;39(2):101–7.
Battaglia C, Battaglia B, Mancini F, Persico N, Nappi RE, Paradisi R, et al. Cigarette smoking decreases the genital vascularization in young healthy, eumenorrheic women. J Sex Med. 2011;8(6):1717–25. The first study to examine genital vasculature effects of smoking in healthy women. Heavy smokers showed reduced genital vasoengorgement compared with nonsmokers and light smokers.
Juenemann KP, Lue TF, Luo JA, Benowitz NL, Abozeid M, Tanagho EA. The effect of cigarette smoking on penile erection. J Urol. 1987;138(2):438–41.
Gilbert DG, Hagen RL, D’Agostino JA. The effects of cigarette smoking on human sexual potency. Addict Behav. 1986;11(4):431–4.
Harte CB, Meston CM. Acute effects of nicotine on physiological and subjective sexual arousal in nonsmoking men: a randomized, double-blind, placebo-controlled trial. J Sex Med. 2008;5(1):110–21.
Harte CB, Meston CM. The inhibitory effects of nicotine on physiological sexual arousal in nonsmoking women: results from a randomized, double-blind, placebo-controlled, cross-over trial. J Sex Med. 2008;5(5):1184–97.
Harte CB, Meston CM. Are the inhibitory effects of nicotine on erectile response in nonsmokers generalizable to long-term smokers? A reply. J Sex Med. 2008;5(8):2003–4.
Chan SS, Leung DY, Abdullah AS, Lo SS, Yip AW, Kok WM, et al. Smoking-cessation and adherence intervention among Chinese patients with erectile dysfunction. Am J Prev Med. 2010;39(3):251–8. A clinical trial of 719 Chinese male smokers with ED who engaged in smoking cessation services. At follow-up, those who quit, compared to those who relapsed, had a nearly two-fold improvement in erectile function.
Sighinolfi MC, Mofferdin A, De Stefani S, Micali S, Cicero AF, Bianchi G. Immediate improvement in penile hemodynamics after cessation of smoking: previous results. Urology. 2007;69(1):163–5.
Guay AT, Perez JB, Heatley GJ. Cessation of smoking rapidly decreases erectile dysfunction. Endocr Pract. 1998;4(1):23–6.
Harte CB, Meston CM. Association between smoking cessation and sexual health in men. BJU Int. 2012;109(6):888–96. The first study to examine whether smoking cessation improves physiological indices of erectile function. Successful quitters, compared to those who relapsed, showed improved erectile responses at post-cessation follow-up, irrespective of baseline ED status.
Kapoor D, Jones TH. Smoking and hormones in health and endocrine disorders. Eur J Endocrinol. 2005;152(4):491–9.
Pomerleau OF. Nicotine and the central nervous system: biobehavioral effects of cigarette smoking. Am J Med. 1992;93(1A):2S–7S.
Hering D, Kucharska W, Kara T, Somers VK, Narkiewicz K. Smoking is associated with chronic sympathetic activation in hypertension. Blood Press. 2010;19(3):152–5. doi:10.3109/08037051.2010.484150.
Mazo E, Gamidov S, Anranovich S, Iremashvili V. Testing endothelial function of brachial and cavernous arteries in patients with erectile dysfunction. J Sex Med. 2005;3(2):323–30.
Rahman MM, Laher I. Structural and functional alteration of blood vessels caused by cigarette smoking: an overview of molecular mechanisms. Curr Vasc Pharmacol. 2007;5(4):276–92.
Wiesmann F, Petersen SE, Leeson PM, Francis JM, Robson MD, Wang Q, et al. Global impairment of brachial, carotid, and aortic vascular function in young smokers: direct quantification by high-resolution magnetic resonance imaging. J Am Coll Cardiol. 2004;44(10):2056–64.
Butler R, Morris AD, Struthers AD. Cigarette smoking in men and vascular responsiveness. Br J Clin Pharmacol. 2001;52(2):145–9.
Lekakis J, Papamichael C, Vemmos C, Nanas J, Kontoyannis D, Stamatelopoulos S, et al. Effect of acute cigarette smoking on endothelium-dependent brachial artery dilatation in healthy individuals. Am J Cardiol. 1997;79(4):529–31.
Burnett AL, Lowenstein CJ, Bredt DS, Chang TS, Snyder SH. Nitric oxide: a physiologic mediator of penile erection. Science. 1992;257(5068):401–3.
Kim N, Azadzoi KM, Goldstein I, Saenz de Tejada I. A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle. J Clin Investig. 1991;88(1):112–8.
Toda N, Ayajiki K, Okamura T. Nitric oxide and penile erectile function. Pharmacol Ther. 2005;106(2):233–66.
Andersson KE. Erectile physiological and pathophysiological pathways involved in erectile dysfunction. J Urol. 2003;170(2):S6–S14.
Brunner H, Cockcroft JR, Deanfield J, Donald A, Ferrannini E, Halcox J, et al. Endothelial function and dysfunction. Part II: association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens. 2005;23(2):233–46.
Higman DJ, Strachan AM, Buttery L, Hicks RC, Springall DR, Greenhalgh RM, et al. Smoking impairs the activity of endothelial nitric oxide synthase in saphenous vein. Arterioscler Thromb Vasc Biol. 1996;16(4):546–52.
Zhang WZ, Venardos K, Chin-Dusting J, Kaye DM. Adverse effects of cigarette smoke on NO bioavailability: role of arginine metabolism and oxidative stress. Hypertension. 2006;48(2):278–85.
Arrick DM, Mayhan WG. Acute infusion of nicotine impairs nNOS-dependent reactivity of cerebral arterioles via an increase in oxidative stress. J Appl Physiol. 2007;103(6):2062–7.
Berman JR, Adhikari SP, Goldstein I. Anatomy and physiology of female sexual function and dysfunction. Eur Urol. 2000;38(1):20–9.
Rosen RC, McKenna KE. PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes. Annu Rev Sex Res. 2002;13:36–88.
D’amati G, di Gioia CR, Bologna M, Giordano D, Giorgi M, Dolci S, et al. Type 5 phosphodiesterase expression in the human vagina. Urology. 2002;60:191–5.
Burnett AL, Calvin DC, Silver RL, Peppas DS, Docimo SG. Immunohistochemical description of nitric oxide synthase isoforms in human clitoris. J Urol. 1997;158:75–8.
Kim SW, Jeong SJ, Munarriz R, Kim NN, Goldstein I, Traish AM. Role of the nitric oxide-cyclic GMP pathway in regulation of vaginal blood flow. Int J Impot Res. 2003;15(5):355–61.
Harte CB. The relationship between resting heart rate variability and erectile tumescence among men with normal erectile function. J Sex Med. 2013;10:1961–8.
Harte CB. Association between cigarette smoking and erectile tumescence: the mediating role of heart rate variability. Int J Impot Res. 2013;25:155–9.
Harte CB. Concurrent relations among cigarette smoking status, resting heart rate variability, and erectile response. J Sex Med. 2014;11:1230–9.
Harte CB. Nicotine acutely inhibits erectile tumescence by altering heart rate variability. Urology. 2014;83:1093–8.
Compliance with Ethics Guidelines
Conflict of Interest
Christopher B. Harte declares that he has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by the author.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Medical Comorbidities
Rights and permissions
About this article
Cite this article
Harte, C.B. Implication of Cigarette Smoking and Cessation on Sexual Function in Men and Women. Curr Sex Health Rep 6, 220–234 (2014). https://doi.org/10.1007/s11930-014-0028-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11930-014-0028-4